NCT00479999View on ClinicalTrials.gov

Phase 1 Safety Study of Two Experimental HIV Vaccines

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

May 24, 2007

Primary Completion Date

May 5, 2014

Study Completion Date

May 5, 2014

Conditions
AIDS VaccinesHIV InfectionsHIV-1
Interventions
DRUG

VRC-HIVADV027-00-VP

DRUG

VRC-HIVADV038-00-VP

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00479999 - Phase 1 Safety Study of Two Experimental HIV Vaccines | Biotech Hunter | Biotech Hunter